original articlesgastrointestinal tumorsEfficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer: the OPUS study
gastrointestinal tumors
Under an Elsevier user license
open archive
Keywords
BRAF
chemotherapy
epidermal growth factor receptor
KRAS
mCRC
predictive
Cited by (0)
Copyright © 2011 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved.